Ancora Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Ancora Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-12	Closed	-$122	–	1837
2023 Q3	$122	Hold	12	–	–	﹤0.01%	1727
2023 Q2	$90	Hold	12	–	–	﹤0.01%	1754
2023 Q1	$106	Hold	12	–	–	﹤0.01%	1890
2022 Q4	$0	Hold	12	–	–	﹤0.01%	1946
2022 Q3	$0	Hold	12	–	–	﹤0.01%	2163
2022 Q2	$0	Hold	12	–	–	﹤0.01%	2330
2022 Q1	$0	Hold	12	–	–	﹤0.01%	2509
2021 Q4	$0	Hold	12	–	–	﹤0.01%	2444
2021 Q3	$0	Hold	12	–	–	﹤0.01%	2293
2021 Q2	$0	Hold	12	–	–	﹤0.01%	2007
2021 Q1	$0	Hold	12	–	–	﹤0.01%	1835
2020 Q4	$0	Hold	12	–	–	﹤0.01%	1534
2020 Q3	$0	Hold	12	–	–	﹤0.01%	1449
2020 Q2	$0	Hold	12	–	–	﹤0.01%	1436
2020 Q1	$0	Sell	12 -700	-98%	-$7.17K	﹤0.01%	1497
2019 Q4	$7K	Buy	+712	New	+$6.36K	﹤0.01%	1227
2018 Q4	–	Sell	-2,037	Closed	-$44K	–	1125
2018 Q3	$44K	Buy	+2,037	New	+$47.3K	﹤0.01%	917
2017 Q1	–	Sell	-5,975	Closed	-$217K	–	1030
2016 Q4	$217K	Buy	5,975 +600	+11%	+$24K	0.02%	541
2016 Q3	$247K	Hold	5,375	–	–	0.03%	440
2016 Q2	$270K	Hold	5,375	–	–	0.03%	409
2016 Q1	$288K	Hold	5,375	–	–	0.04%	389
2015 Q4	$353K	Sell	5,375 -53	-1%	-$3.27K	0.05%	359
2015 Q3	$306K	Hold	5,428	–	–	0.04%	383
2015 Q2	$321K	Buy	+5,428	New	+$335K	0.04%	389
2015 Q1	–	Sell	-5,428	Closed	-$316K	–	375
2014 Q4	$312K	Buy	+5,428	New	+$302K	0.04%	389
2014 Q1	–	Sell	-7,500	Closed	-$301K	–	461
2013 Q4	$301K	Sell	7,500 -500	-6%	-$19.7K	0.05%	324
2013 Q3	$302K	Sell	8,000 -500	-6%	-$19.5K	0.05%	310
2013 Q2	$333K	Buy	+8,500	New	+$331K	0.06%	294

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAM

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Ancora Advisors's TEVA Position: Q4 2023 in Review

Ancora Advisors sold out of Teva Pharmaceuticals (TEVA) in Q4 2023, closing a stake of 12 shares — an estimated $122 sold.

Ancora Advisors first reported a position in TEVA in Q2 2013 and held it in 28 quarters. The position peaked at $353K in Q4 2015. 447 funds tracked by Wall St. Rank hold TEVA as of Q4 2023.

Ancora Advisors reported no remaining Teva Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
Ancora Advisors sold 12 Teva Pharmaceuticals shares in Q4 2023, an estimated $122.
Ancora Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 28 quarters.
Ancora Advisors's Teva Pharmaceuticals position peaked at $353K in Q4 2015.
447 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2023.

Based on Ancora Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.